Stay updated on Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a note that publications are auto-filled from PubMed and updated the revision to v3.3.2; the previous PubMed-origin note and v3.2.0 revision were removed.
    Difference
    0.1%
    Check dated 2025-11-24T16:51:55.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice from the page. The study details, eligibility criteria, and outcomes remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T14:59:33.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    No substantive changes detected in the study record between the two screenshots. The page continues to display the same study title, conditions, eligibility criteria, and planned interventions.
    Difference
    0.5%
    Check dated 2025-11-03T01:30:54.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    4%
    Check dated 2025-10-05T10:18:41.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.1%
    Check dated 2025-09-28T03:16:52.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, indicating a version update. The 'Back to Top' element was removed as a minor UI change.
    Difference
    0.3%
    Check dated 2025-09-13T17:09:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Trastuzumab Combo in HER2+ Gastric Cancer Clinical Trial page.